Back
Pliant Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
PLRX
Pliant Therapeutics
Last Price:
$1.40
Seasonality Move:
22.02%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.31 | Buy |
20-day SMA: | 1.3 | Buy |
50-day SMA: | 1.39 | Buy |
200-day SMA: | 7.05 | Sell |
8-day EMA: | 0.99 | Buy |
20-day EMA: | 0.54 | Buy |
50-day EMA: | 0.25 | Buy |
200-day EMA: | 0.07 | Buy |
Pliant Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 57.75 | Buy |
Chaikin Money Flow: | 35286 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.21 - 1.47) | Buy |
Bollinger Bands (100): | (1.08 - 2.08) | Sell |
Pliant Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.45 while PLRX 8-day simple moving average is 1.31, which is a Buy signal.
-
The stock price of PLRX is 1.45 while Pliant Therapeutics 20-day SMA is 1.30, which makes it a Buy.
-
Pliant Therapeutics 50-day simple moving average is 1.39 while PLRX share price is 1.45, making it a Buy technically.
-
PLRX stock price is 1.45 and Pliant Therapeutics 200-day simple moving average is 7.05, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
50
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a SellThe current Pliant Therapeutics [PLRX] share price is $1.45. The Score for PLRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
89M
Price in USD:
1.45
Share Volume:
670.4K
Pliant Therapeutics 52-Week Range
52-Week High:
16.10
52-Week Low:
1.10
Sell
50
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?The Pliant Therapeutics stock price is 1.45 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.45 while PLRX 8-day exponential moving average is 0.99, which is a Buy signal.
-
The stock price of PLRX is 1.45 while Pliant Therapeutics 20-day EMA is 0.54, which makes it a Buy.
-
Pliant Therapeutics 50-day exponential moving average is 0.25 while PLRX share price is 1.45, making it a Buy technically.
-
PLRX stock price is 1.45 and Pliant Therapeutics 200-day simple moving average is 0.07, creating a Buy signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.09 per share, and an increase next year of $0.08 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting Pliant Therapeutics is a Buy
-
Pliant Therapeutics Relative Strength Index (RSI) is 57.75, which suggest Pliant Therapeutics is overbought
-
The Bollinger Bands (25) for Pliant Therapeutics is (1.21 - 1.47), which suggest Pliant Therapeutics is a Sell
-
The Bollinger Bands (100) for Pliant Therapeutics is (1.08 - 2.08), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.